outcomes research

Research in Review

Small Study Suggests Nivolumab Does Not Improve Outcomes in Patients With Lung Cancer and Liver Metastases

03/16/2017

JCP Editors

None of the patients in a study with lung cancer and hepatic metastases experienced an objective response in their liver tumors after anti-PD1 therapy, according to research presented at ASCO’s Society for...

None...

03/16/2017

Journal of Clinical Pathways

Pharma Insights

The Role of Payers in Antibiotic Stewardship: Facilitating Transitions of Care for Patients With Active Infection

03/15/2017

Jeremy Schafer , PharmD, MBA;

All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...

All...

03/15/2017

Journal of Clinical Pathways

Department

Follow-up Guidelines Needed for Young Adult Cancer Survivors

03/15/2017

JCP Editors

Many young adult (YA) cancer survivors are unaware of potential long-term adverse effects of cancer therapies and of the necessity of follow-up care, according to a focus group of survivors aged between 18 and 39...

Many...

03/15/2017

Journal of Clinical Pathways

Research in Review

International Guidelines Issued for Management of Sepsis, Septic Shock

03/15/2017

JCP Editors

The Surviving Sepsis Campaign, with the Society of Critical Care Management and the European Society of Intensive Care Medicine, published international guidelines for the management of sepsis and septic shock in...

The...

03/15/2017

Journal of Clinical Pathways

Research in Review

Neurofeedback Reduces Nerve Damage From Chemo in Cancer Survivors

03/13/2017

JCP Editors

Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...

...

03/13/2017

Journal of Clinical Pathways

Research in Review

Single, High-Dose Brachytherapy Effective in Patients With Localized Prostate Cancer

03/06/2017

JCP Editors

High-dose-rate brachytherapy administered in a single treatment may be a safe and effective alternative for patients with non-metastatic prostate cancer, according to a new study. ----- Related Content Surgery...

...

03/06/2017

Journal of Clinical Pathways

Research in Review

Adding Androgens to Maintenance Therapy Improves Survival in Older Patients With AML

03/01/2017

JCP Editors

Maintenance therapy with androgens significantly improves survival in older patients with acute myeloid leukemia (AML) without increasing toxicity, according to research published in the Journal of Clinical Oncology...

...

03/01/2017

Journal of Clinical Pathways

Research in Review

Genomic Profiling, Targeted Therapy Effectively Treats Histiocytic Disorders

02/17/2017

JCP Editors

Genomic profiling should be applied to patients with histiocytic disorders at diagnosis in order to guide targeted therapy, according to research published in the Journal of Clinical Investigation Insight (February...

...

02/17/2017

Journal of Clinical Pathways

Research in Review

Study: Newer NSCLC Therapies Have Limited Real-World Survival Benefit, High Costs

02/14/2017

JCP Editors

Therapies recently approved to treat advanced-stage non-small cell lung cancer (NSCLC) confer an average of 1.5-month survival increase and an $8,000 increase in outpatient spending per patient, according to a study...

...

02/14/2017

Journal of Clinical Pathways

Research in Review

Prior Antibiotics May Reduce Immunotherapy Efficacy in Patients With Cancer

02/14/2017

JCP Editors

Patients with cancer who receive antibiotics within a month before beginning their immunotherapy treatment may find the efficacy of their treatment reduced, according to a study that will be presented at the...

...

02/14/2017

Journal of Clinical Pathways